Essex Financial Services’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,365
Closed -$100K 762
2025
Q2
$100K Sell
10,365
-43,451
-81% -$448K 0.01% 681
2025
Q1
$801K Sell
53,816
-655
-1% -$10.1K 0.06% 282
2024
Q4
$813K Sell
54,471
-3,355
-6% -$54.7K 0.06% 278
2024
Q3
$1M Sell
57,826
-1,633
-3% -$33.8K 0.07% 243
2024
Q2
$1.16M Buy
59,459
+12,164
+26% +$242K 0.09% 210
2024
Q1
$889K Buy
47,295
+3,573
+8% +$61.3K 0.08% 224
2023
Q4
$630K Buy
43,722
+17,533
+67% +$239K 0.07% 259
2023
Q3
$455K Buy
26,189
+1,965
+8% +$41K 0.05% 298
2023
Q2
$504K Buy
+24,224
New +$527K 0.06% 276

Other funds holding OGN

Essex Financial Services's OGN Position: Q3 2025 in Review

Essex Financial Services sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 10,365 shares — an estimated $100K sold.

Essex Financial Services first reported a position in OGN in Q2 2023 and held it in 9 quarters. The position peaked at $1.16M in Q2 2024. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • Essex Financial Services reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • Essex Financial Services sold 10,365 Organon & Co shares in Q3 2025, an estimated $100K.
  • Essex Financial Services first reported a position in Organon & Co in Q2 2023 and held it in 9 quarters.
  • Essex Financial Services's Organon & Co position peaked at $1.16M in Q2 2024.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Essex Financial Services's 13F filing for Q3 2025, filed 7 Nov 2025.